Relationship Between T LYmphocytes Depletion and Clinical Response to RITUXimab in Rheumatoid Arthritis (LYRITUX)
Phase of Trial: Phase III
Latest Information Update: 27 Oct 2016
At a glance
- Drugs Rituximab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms LYRITUX
- 07 Jun 2017 Biomarkers information updated
- 23 Mar 2015 Planned End Date changed from 1 May 2018 to 1 Dec 2018 as reported by ClinicalTrials.gov record.
- 23 Mar 2015 Planned primary completion date changed from 1 May 2018 to 1 Sep 2018 as reported by ClinicalTrials.gov record.